Trial Profile
Correlation Between Hyperreflective Foci and Clinical Outcomes in Neovascular Age-Related Macular Degeneration After Switching to Aflibercept
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 05 Feb 2016 New trial record